Kailo Labs Launches the World’s First Nanotech Bio-Antenna for Pain Relief

Kailo Labs, an Utah-based nanotech startup, has launched the world's first nanotechnology-based bio-antenna for easy pain relief.  Full story.  
Topics:

Diagnosis and Management of Sensory Polyneuropathy

 Sensory polyneuropathies, which are caused by dysfunction of peripheral sensory nerve fibers, are a heterogeneous group of disorders that range from the common diabetic neuropathy to the rare sensory neuronopathies. The presenting symptoms, acuity, time course, severity, and subsequent morbidity vary and depend on the type of fiber that is affected and the underlying cause. Damage to small thinly myelinated and unmyelinated nerve fibers results in neuropathic pain, whereas damage to large myelinated sensory afferents results in proprioceptive deficits and ataxia.
Continue reading
Topics:

Chemist IDs Possible Addiction-Free Pain Reliever

 A naturally occurring enzyme, called diacylglycerol lipase-beta, or DAGLb, is a possible new drug target for reducing pain. Full story.  

Chronic Use of Tramadol after Acute Pain Episode: Cohort Study

To determine the risk of prolonged opioid use in patients receiving tramadol compared with other short acting opioids. Opioid-naive patients undergoing elective surgery. Risk of persistent opioid use after discharge for patients treated with tramadol alone compared with other short acting opioids, using three commonly used definitions of prolonged opioid use from the literature: additional opioid use (defined as at least one opioid fill 90-180 days after surgery); persistent opioid use (any span of opioid use starting in the 180 days after surgery and lasting ≥90 days); and CONSORT definition (an opioid use episode starting in the 180 days after surgery that spans ≥90 days and includes either ≥10 opioid fills or ≥120 days' supply of opioids).

Continue reading

Hospitals Testing Virtual Reality to Improve Pain Management

Hospitals are experimenting with virtual reality to see if it can reduce pain, enhance the effect of medication, and lower the chances a patient is admitted.  Full story.  
Topics:

Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial

There is a significant unmet need for novel effective well‐tolerated acute migraine treatments. REN is a novel acute migraine treatment that stimulates upper arm peripheral nerves to induce conditioned pain modulation – ...
Continue reading

New Opioid Speeds Up Recovery Without Increasing Pain Sensitivity or Risk of Chronic Pain

A novel opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System is as strong as morphine but isn't addictive and causes fewer side effects, according to a new study published in the Journal of Neuroinflammation

Continue reading

Oregon Panel Drops Effort to Cut Opioids and Cover Chronic Pain

An Oregon committee has abandoned a controversial proposal that would have expanded treatment options for chronic pain patients under the Oregon Health Plan, but would have forced many to reduce dosages or discontinue pr...
Continue reading

Comparative Effectiveness of Analgesics to Reduce Acute Pain in the Prehospital Setting Report

The Evidence-based Practice Center (EPC) Program at the Agency for Healthcare Research and Quality (AHRQ) has posted the draft report for the systematic review on Comparative Effectiveness of Analgesics to Reduce Acute P...
Continue reading
Topics:

Patient-Centered Care Is Key to Best Practices in Pain Management

Vanila M. Singh, MD MACM, Chairperson of the HHS Pain Management Inter-Agency Task Force, is interviewed about the task force's recommendations for treating acute and chronic pain. Full story.
Topics:
HHS

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More